Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Suan ZaoRen Tang-TianWang BuXin Dan in Chronic Insomnia
NCT06511011Phase 2Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Sep 2025
- Primary completion
- May 2027
- Modality
- HM (Herbal Medicine), TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia comparing mSZT-TBD granules with Placebo granules (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index at 6 weeks. Started Sep 2025; status: recruiting.
02
Drugs
Modified Suan Zao Ren Tang + Tian Wang Bu Xin Dan
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT06511011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06511011.